Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismail Reisli

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
The Journal of Allergy and Clinical Immunology|March 1, 2015
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiencyKarin R Engelhardt, Michael E Gertz, Sevgi Keles, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 20, 2022
The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of ImmunitySafa Baris, Hassan Abolhassani, Michel J Massaad, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiencyNigar Taghizade, Royala Babayeva, Altan Kara, et al.
Frontiers in Genetics|August 27, 2025
Clinical and molecular findings in actin-related inborn errors of immunity: the middle East and North Africa registryZahra Chavoshzadeh, Shahrzad Fallah, Vahide Zeinali, et al.
Science Immunology|December 23, 2018
Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common <i>TYK2</i> missense variantStéphanie Boisson-Dupuis, Noe Ramirez-Alejo, Zhi Li, et al.
Frontiers in Immunology|January 6, 2023
Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021Hassan Abolhassani, Tadej Avcin, Nerin Bahceciler, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
The Journal of Allergy and Clinical Immunology|March 1, 2015
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiencyKarin R Engelhardt, Michael E Gertz, Sevgi Keles, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 20, 2022
The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of ImmunitySafa Baris, Hassan Abolhassani, Michel J Massaad, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2023
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiencyNigar Taghizade, Royala Babayeva, Altan Kara, et al.
Frontiers in Genetics|August 27, 2025
Clinical and molecular findings in actin-related inborn errors of immunity: the middle East and North Africa registryZahra Chavoshzadeh, Shahrzad Fallah, Vahide Zeinali, et al.
Science Immunology|December 23, 2018
Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common <i>TYK2</i> missense variantStéphanie Boisson-Dupuis, Noe Ramirez-Alejo, Zhi Li, et al.
Frontiers in Immunology|January 6, 2023
Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021Hassan Abolhassani, Tadej Avcin, Nerin Bahceciler, et al.
Pageof 14